Metro Minnesota CCOP — Saint Louis Park, Minnesota

Metro Minnesota CCOP is a clinical research site located in Saint Louis Park, Minnesota, United States 55416.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Metro Minnesota CCOP has participated in 10 clinical trials with 3 currently active.

Therapeutic areas: Breast Neoplasms, Osteoporosis, Primary Immune Thrombocytopenia (ITP).

Sponsors: Novartis Pharmaceuticals, Novartis, Elevation Oncology.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Metro Minnesota CCOP?

Metro Minnesota CCOP has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Metro Minnesota CCOP conducted?

Metro Minnesota CCOP has 10 clinical trials on record, with 3 currently active. Their work covers Breast Neoplasms, Osteoporosis, Primary Immune Thrombocytopenia (ITP).

Is Metro Minnesota CCOP accredited by Crixeo Health?

Yes — Metro Minnesota CCOP holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Metro Minnesota CCOP?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.